This story has been updated from a previous version.

NEW YORK, June 6 – Amersham Pharmacia Biotech announced Tuesday an agreement to supply their Ettan proteomics system to Dallas' Center for Biotechnology and Bioinformatics at the University of Texas and the Alliance for Cellular Signaling at the University of Texas Southwestern Medical Center. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.